等待开盘 12-20 09:30:00 美东时间
-0.185
-1.64%
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
12-17 10:46
Dentsply Sirona (XRAY) declares $0.16/share quarterly dividend, in line with previous. Forward yield 5.53% Payable Jan. 9; for shareholders of record Dec. 26; ex-div Dec. 26. See XRAY Dividend Scoreca...
12-15 21:08
Charlotte, N.C., Dec. 15, 2025 — DENTSPLY SIRONA Inc. announced a quarterly cash dividend of $0.16 per share, totaling $0.64 annually. The dividend will be paid on January 9, 2026, to shareholders of record as of December 26, 2025. Dentsply Sirona is the world's largest manufacturer of dental products and technologies, offering innovative solutions to advance patient care. Shares are listed on Nasdaq under XRAY.
12-15 13:00
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
12-10 10:33
Barclays analyst Glen Santangelo initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Underweight rating and announces Price Target of $12.
12-09 23:38
Dentsply Sirona (XRAY) ticks up after the company announced the appointment of Michael Pomeroy as interim CFO, who will serve in this temporary capacity until a permanent appointment. The stock is up ...
11-26 03:41
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 17:17
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 10:22
On November 6, 2025, DENTSPLY SIRONA Inc. (the "Company") filed a Current Report on Form 8-K (the "Original Report") reporting that the Company had determined that Matthew E. Garth will no longer serve as the Executive
11-08 05:52